COHEN JOSHUA B (Co-Chief Executive Officer) received a stock award from AMYLYX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/9/2026ACC: 0001193125-26-098440
DirectorOfficer· Co-Chief Executive Officer
Since Jan 2022
+622.16K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
622.16K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+248.87K
Price / share
—
Trade value
—
% of position
7.5%
3/5/2026
3.33M→3.58M
Total
Net shares
+248.87K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | A · Award | +248.87K | — | — | 7.5% | 3.33M | 3.58M |
| Total | +248.87K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
373.30K shares
Shares
+373.30K
Strike price
14.10
Held after
373.30K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock373.30K shares | 3/5/2026 | A · Award | +373.30K | 14.10 | — | 373.30K |